ParcelBio
ActiveElevated mRNA for transformative medicines.
What it does
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
Its site says now · captured 2026-08-23
ParcelBio
Elevated mRNA for transformative medicines
Next to it in Healthcare and bio · mRNA therapeutics platform
- Velorum TherapeuticsY Combinator W24
Breakthrough medicines unlocking the biology of heme
- BRCĒTechstars TS 2024
BRCĒ - Performance Athletic Shoelaces
- Nunatak BiotechTechstars TS 2024
Home | Nunatak
- Opal TherapeuticsTechstars TS 2024
Opal Therapeutics | Advance Women's Health Today
- Scioto BiosciencesPlug and Play PnP 2025
Scioto is a preclinical stage company developing innovative therapies devoted to having a transformative impact.
- Catena BiosciencesY Combinator S21
Using protein coupling to build new therapies
- SafeBeatY Combinator S21
Guiding cardiac therapeutics - all from your phone
- OpenBiomeY Combinator W20
A nonprofit stool bank enabling access to fecal transplants.